Cellectar Biosciences, Inc. (CLRB)
NASDAQ: CLRB · Real-Time Price · USD
2.770
0.00 (0.00%)
At close: Mar 6, 2026, 4:00 PM EST
2.760
-0.010 (-0.36%)
After-hours: Mar 6, 2026, 5:19 PM EST
Cellectar Biosciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Selling, General & Admin | 11.48 | 25.64 | 11.69 | 10.55 | 6.54 | |
| Research & Development | 11.5 | 26.14 | 27.27 | 18.27 | 17.59 | |
| Operating Expenses | 22.98 | 51.78 | 38.96 | 28.81 | 24.13 | |
| Operating Income | -22.98 | -51.78 | -38.96 | -28.81 | -24.13 | |
| Interest & Investment Income | 0.44 | 1.21 | 0.39 | 0.15 | 0 | |
| Other Non Operating Income (Expenses) | 0.75 | 6.05 | -4.26 | -3.19 | 0.01 | |
| EBT Excluding Unusual Items | -21.79 | -44.52 | -42.83 | -31.85 | -24.12 | |
| Pretax Income | -21.79 | -44.52 | -42.83 | -31.85 | -24.12 | |
| Income Tax Expense | - | 0.07 | -0.06 | -0.06 | - | |
| Net Income | -21.79 | -44.58 | -42.77 | -31.79 | -24.12 | |
| Net Income to Common | -21.79 | -44.58 | -42.77 | -31.79 | -24.12 | |
| Shares Outstanding (Basic) | 3 | 1 | 0 | 0 | 0 | |
| Shares Outstanding (Diluted) | 3 | 1 | 0 | 0 | 0 | |
| Shares Change (YoY) | 110.67% | 203.92% | 73.22% | 27.09% | 180.20% | |
| EPS (Basic) | -8.35 | -36.52 | -104.99 | -135.18 | -130.35 | |
| EPS (Diluted) | -8.35 | -41.89 | -105.00 | -135.18 | -130.35 | |
| Free Cash Flow | -23.12 | -47.69 | -33.24 | -25.45 | -22.71 | |
| Free Cash Flow Per Share | -8.87 | -38.52 | -81.60 | -108.20 | -122.72 | |
| EBITDA | -22.77 | -51.49 | -38.77 | -28.67 | -23.98 | |
| D&A For EBITDA | 0.21 | 0.29 | 0.19 | 0.15 | 0.15 | |
| EBIT | -22.98 | -51.78 | -38.96 | -28.81 | -24.13 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.